Pfizer and Serum Institute of India have both applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for their respective COVID-19 vaccine in India. This comes days after the United Kingdom and Bahrain formally approved the Pfizer-BioNTech COVID-19 vaccine for emergency use.
Meanwhile, Bharat Biotech’s Phase-3 clinical trial design for its candidate Covaxin expects 130 COVID-19 infections among trial participants, according to details shared by the company on the government’s clinical trial website. This clarification comes after news of Haryana Health Minister Anil Vij testing positive for COVID-19 two weeks after being vaccinated as a trial participant set off a bout of panic.
Here are the updates:
Active caseload falls below 4 lakh in country
India’s coronavirus infections rose to 96.77 lakh, while the active caseload fell below 4 lakh and the recoveries surged to 91.39 lakh, according to the Union Health Ministry data updated on Monday.
The total coronavirus cases mounted to 96,77,203 with 32,981 new infections being reported in a day, while the death toll rose to 1,40,573 with 391 new fatalities, the data updated at 8 a.m. showed.
There are 3,96,729 active coronavirus infections in the country which comprises 4.10% of the total caseload, the data stated.
The number of people who have recuperated from the disease surged to 91,39,901 pushing the national recovery rate to 94.45%, while the COVID-19 case fatality rate stands at 1.45%. – PTI
About 130 Covaxin trial volunteers may test positive, says Bharat Biotech
Vaccine maker Bharat Biotech’s Phase-3 clinical trial design for its candidate Covaxin expects 130 COVID-19 infections among trial participants, according to details shared by the company on the government’s clinical trial website.
Thus instances such as Haryana Health Minister Anil Vij testing positive for COVID-19 two weeks after being vaccinated as a trial participant, are expected.
Significant decline in ICU cases
There has been a significant decline in the number of critical COVID-19 patients being monitored in Intensive Care Units (ICUs) of various hospitals in November and early December.
As on December 6, while four districts had zero ICU cases, Bengaluru Urban had the highest with 143. The next highest was Tumakuru at 23. Uttara Kannada, Koppal, Chitradurga, and Haveri had one case each.
After seeing above 900 critical cases till the end of October, the State witnessed a decline in the number of critical patients since November 6 when cases fell in the under 900 bracket.
Following this, there was a further reduction and cases hovered around 800 till November 12.
COVID cases declining despite increased testing
Notwithstanding a comparatively higher number of tests, fewer COVID-19 cases have been detected in Telangana since December 1. On Saturday, 57,308 samples were put to test and only 622 were found to be positive for coronavirus while results of 848 people were awaited.
In terms of daily testing from March 2, when the first case emerged in the State, till December 5, the highest number of tests were conducted only for a few weeks spread between August and September, leading to detection of maximum cases.